STAT
NOVEMBER 3, 2023
More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The tracker has collected data on Medicaid enrollment since the first states began redetermining eligibility in April, after the expiration of the federal requirement of continuous coverage during the Covid-19 public health emergency.
ALiEM - Pharm Pearls
NOVEMBER 3, 2023
Welcome to the AIR Trauma Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to related to trauma in the Emergency Department. 8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 3, 2023
I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic fibrosis drug Trikafta. Five years later, the worst parts of my CF are gone. I recently recovered from a viral infection that provoked a pneumonia-like illness without landing in a hospital tied to an oxygen tank.
PharmaVoice
NOVEMBER 3, 2023
From biotech startups to a services agency, these entrepreneurs are hedging their bets to offer innovative approaches in patient care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 3, 2023
’Tis the season — open enrollment season, that is. Since before the Nov. 1 start to the annual open enrollment period, the advertising engines for state health insurance marketplaces, and the federal exchange, healthcare.gov , have been revving up. The nation’s uninsurance rate is down to 7.7% — the lowest it has ever been.
BioPharma Dive
NOVEMBER 3, 2023
The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
NOVEMBER 3, 2023
Pharmacists have called for greater awareness of the profession after an MP appeared to mistakenly refer to the profession as ‘pharmacologists’ on BBC Question Time last night. Member of Parliament for Horsham and Cabinet Office minister Jeremy Quin highlighted the roles of ‘pharmacologists’ working in general practice in response to a comment made by a […] The post Pharmacists call for greater awareness following Question Time comment appeared first on The Pharmacist.
STAT
NOVEMBER 3, 2023
The federal government is moving forward with a spate of proposals that will force hospitals to be better about publishing the prices they charge health insurers and patients. Federal law has required hospitals to post their prices since 2021. Compliance has been dismal , although it has improved since the government increased fines a few years ago.
Pharma Times
NOVEMBER 3, 2023
Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented - News - PharmaTimes
STAT
NOVEMBER 3, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. There’s potential that a stem cell infusion from kidney donors might help prevent organ rejection — allowing patients to perhaps wean from immunosuppressive drugs. We see the Senate is getting serious about PBMs, and have a neat podcast, as always.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
NOVEMBER 3, 2023
The pharma sector is slowly shedding its image as a digital laggard. The jolt from the COVID pandemic saw many companies hasten their digital transformation journey. Many of the early birds are tasting the low-hanging fruits of these forays. But a lot still needs to be done to truly catch up with other sectors. So what are the best practices and learnings of these pharma digital torchbearers?
STAT
NOVEMBER 3, 2023
Most of the formularies run by some of the largest health plans in the U.S. generally provide “fair access” to 18 treatments for a handful of serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis has found. Almost uniformly, the 19 formularies made the medicines available fairly when judged on three criteria: eligibility based on clinical data, restrictions placed on prescribers, and step therapy, which requires patients to
The Pharmacist
NOVEMBER 3, 2023
Weekly insulin injections may be the future of diabetic care and could replace daily insulin injections, according to a study undertaken by the University of Surrey. A year-long phase three trial has shown that weekly injections of insulin icodec could be used to manage type 1 diabetes as effectively as daily basal insulin treatments. The […] The post Study finds potential for weekly insulin injections in diabetes care appeared first on The Pharmacist.
STAT
NOVEMBER 3, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return next week.
Express Pharma
NOVEMBER 3, 2023
Lupin and Zydus Lifesciences have entered into a licensing and supply agreement to co-market, Saroglitazar Mg for the treatment of NonAlcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Under the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
STAT
NOVEMBER 3, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, is exceedingly modest. We will attempt to employ a new device for moving leaves about the official grounds, catch up on our reading and perhaps hold another listening party.
PharmaTech
NOVEMBER 3, 2023
Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
Pharma Times
NOVEMBER 3, 2023
Over 63,000 cancer cases were diagnosed between one and five years after referral - News - PharmaTimes
PharmExec
NOVEMBER 3, 2023
Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder.
The Thyroid Pharmacist
NOVEMBER 3, 2023
Got reflux? I had reflux, too. It started with a chronic cough, pain, burning, and choking sensation. I tried every over-the-counter product possible. I saw my primary care doctor, an allergist, a gastroenterologist, and an ear, nose, and throat doctor. I even had a barium swallow test where I swallowed a nasty, chalky substance, and the test revealed I had a sliding hiatal hernia with spontaneous reflux.
Express Pharma
NOVEMBER 3, 2023
The Organisation of Pharmaceutical Producers of India (OPPI) organised the OTC Health and Wellness Conference 2023 at PHD House, New Delhi, with the objective of promoting responsible self-care among individuals. The conference aimed to provide evidence-based information on the appropriate use and safety of over the counter (OTC) medications to consumers.
European Pharmaceutical Review
NOVEMBER 3, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Litfulo’s active ingredient, ritlecitinib, is an enzyme inhibitor. It works irreversibly and selectively inhibits Janus kinase 3 (JAK3) and the tyrosine (TEC) family of kinases by blocking γ-common cytokine signalling and reduc
Drug Channels
NOVEMBER 3, 2023
Today’s guest post comes from Greg Morris, Chief Strategy Officer at CareMetx. Greg highlights the value of therapeutic area expertise in enhancing the performance of hub services. He explains how CareMetx's hub used its experience in the retina space to improve a new brand-name product’s launch. To learn more about the impact of hub service on brand launch success, download CareMetx’s latest report: Patient Service Trends Point the Way to Better Hub/ Provider Partnerships.
Outsourcing Pharma
NOVEMBER 3, 2023
From Disney to the drug world, Liss Easy has had a fascinating journey to where she is now in her role as vice president and general manager of clinical operations at IQVIA.
The Pharmacist
NOVEMBER 3, 2023
Action to prevent cardiovascular disease ‘can go further’ with support from pharmacy professionals, the chief medical officer (CMO) for England has stressed. Speaking at the King’s Fund annual conference this week, Professor Chris Whitty said prevention for cardiovascular disease must be extended out of general practice and into the ‘entire medical, nursing and pharmacy professions’. […] The post CMO: Cardiovascular disease prevention ‘can go further’ with pharmacy support appeared first o
World Pharma News
NOVEMBER 3, 2023
Metabolites called nucleotides are the building blocks of DNA and can impact cancer's sensitivity or resistance to chemotherapy and radiation in brain cancer. Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way.
The Pharmacist
NOVEMBER 3, 2023
A rapid rollout of direct oral anticoagulants (DOACs) for people with atrial fibrillation (AF) has saved thousands of lives and is six years ahead of target, NHS England has said. In a keynote speech to the King’s Fund annual conference this week, NHS chief executive Amanda Pritchard highlighted estimates that almost 17,000 strokes had been […] The post Rapid DOACs rollout for AF ‘six years ahead of target’ appeared first on The Pharmacist.
Welltopia Pharmacy
NOVEMBER 3, 2023
The Importance of Calcium for Bone Health & It The Crucial Role in Building Strong Bones Introduction: Bones are the The post The Importance of Calcium for Bone Health & It The Crucial Role in Building Strong Bones first appeared on Welltopia Compounding Pharmacy.
PharmExec
NOVEMBER 3, 2023
The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines.
pharmaphorum
NOVEMBER 3, 2023
Scientists in the C-Suite: Attracting investors takes more than good science Mike.
Pharmaceutical Business Review
NOVEMBER 3, 2023
This acquisition will expand the range of services available to Noramco and its subsidiary Purisys’ active pharmaceutical ingredients (API) customers. The services include drug product formulation development, clinical and commercial drug product manufacturing, and packaging from facilities that are located in Whippany, New Jersey, in the US, and Mirabel, Quebec, in Canada.
Drug Patent Watch
NOVEMBER 3, 2023
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seventeen patents protecting… The post New patent expiration for Novartis drug LEQVIO appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
NOVEMBER 3, 2023
Study finds higher cancer rate in patients given ‘all clear’ Phil.
Drug Patent Watch
NOVEMBER 3, 2023
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are sixteen… The post New patent expiration for Alnylam Pharms drug ONPATTRO appeared first on DrugPatentWatch - Make Better Decisions.
Pharmafile
NOVEMBER 3, 2023
Phathom Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Voquenza (vonoprazan) tablets 10mg and 20mg, a novel potassium-competitive acid blocker (PCAB). The drug is approved as a treatment for adult patients for the healing of all grades of Erosive Esophagitis – also known as Erosive gastrointestinal reflux disease (GERD ) […] The post FDA approves Phathom Pharmaceuticals’ Voquezna for erosive GERD appeared first on Pharmafile.
Expert insights. Personalized for you.
361 
Let's personalize your content